Home › Funds › Cannell & Spears LLC › LH

Cannell & Spears LLC position in LH

LABCORP HOLDINGS INC · Health Care

Cannell & Spears LLC reported holding 144,949 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$44.7M, representing 0.82% of its reported portfolio and ranking #35 among its reported holdings. Cannell & Spears LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)144.95K sh
Reported value held$44.66M
Portfolio Weight0.82%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cannell & Spears LLC's LH position evolved

Cannell & Spears LLC first disclosed a stake in LH in Q3 2023 at 5,050 shares (US$1.0M). The position peaked in Q1 2024 at 342,871 shares, worth US$74.9M. Across 13 filings, Cannell & Spears LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 144,949 shares valued at US$44.7M — a reduction of -5,088 shares quarter over quarter.. Notable position changes include a 6690% increase in Q1 2024 (shares fell 7% over the following quarter), a 52% trim in Q2 2024 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.05K $1.02M New
Q4 2023 5.05K $1.15M Hold
Q1 2024 342.87K $74.90M Add
Q2 2024 165.34K $33.65M Reduce
Q3 2024 170.30K $38.06M Add
Q4 2024 202.56K $46.45M Add
Q1 2025 164.42K $38.27M Reduce
Q2 2025 162.52K $42.66M Reduce
Q3 2025 159.58K $45.81M Reduce
Q4 2025 158.56K $39.78M Reduce
Q1 2026 151.54K $40.43M Reduce
Q2 2026 150.04K $42.01M Reduce
Q3 2026 144.95K $44.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has Cannell & Spears LLC held LH?

Cannell & Spears LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cannell & Spears LLC's current position in LH?

As of Q3 2026, Cannell & Spears LLC holds 144.95K shares of LH (LABCORP HOLDINGS INC), valued at $44.66M, representing 0.82% of its reported portfolio and ranking #35.

Has Cannell & Spears LLC been buying or selling LH?

In the latest 13F filing (Q3 2026), Cannell & Spears LLC reduced its position in LH. The position peaked in Q1 2024 at 342.87K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.